Tower Research Capital (TRC)’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Sell |
|
|||||
|
2025
Q1 | $214K | Sell |
|
|||||
|
2024
Q4 | $270K | Buy |
|
|||||
|
2024
Q3 | $259K | Sell |
|
|||||
|
2024
Q2 | $731K | Buy |
|
|||||
|
2024
Q1 | $575 | Sell |
|
|||||
|
2023
Q4 | $82.3K | Sell |
|
|||||
|
2023
Q3 | $310K | Buy |
|
|||||
|
2023
Q2 | $53.8K | Sell |
|
|||||
|
2023
Q1 | $198K | Sell |
|
|||||
|
2022
Q4 | $725K | Buy |
|
|||||
|
2022
Q3 | $13K | Sell |
|
|||||
|
2022
Q2 | $681K | Buy |
|
|||||
|
2022
Q1 | $1K | Sell |
|
|||||
|
2021
Q4 | $872K | Sell |
|
|||||
|
2021
Q3 | $1.19M | Sell |
|
|||||
|
2021
Q2 | $1.91M | Sell |
|
|||||
|
2021
Q1 | $1.69M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3.47M | Buy |
|
|||||
|
2020
Q2 | $15K | Sell |
|
|||||
|
2020
Q1 | $41K | Sell |
|
|||||
|
2019
Q4 | $1.32M | Buy |
|
|||||
|
2019
Q3 | $202K | Sell |
|
|||||
|
2019
Q2 | $3.34M | Buy |
|
|||||
|
2019
Q1 | $539K | Sell |
|
|||||
|
2018
Q4 | $1.11M | Sell |
|
|||||
|
2018
Q3 | $1.89M | Buy |
|
|||||
|
2018
Q2 | $612K | Buy |
|
|||||
|
2018
Q1 | $9K | Sell |
|
|||||
|
2017
Q4 | $2.69M | Buy |
|
|||||
|
2017
Q3 | $4K | Sell |
|
|||||
|
2017
Q2 | $1.45M | Buy |
|
|||||
|
2017
Q1 | $375K | Sell |
|
|||||
|
2016
Q4 | $898K | Sell |
|
|||||
|
2016
Q3 | $2.48M | Sell |
|
|||||
|
2016
Q2 | $4.27M | Buy |
|
|||||
|
2016
Q1 | $3.79M | Buy |
|
|||||
|
2015
Q4 | $1.9M | Buy |
|
|||||
|
2015
Q3 | $78K | Sell |
|
|||||
|
2015
Q2 | $754K | Sell |
|
|||||
|
2015
Q1 | $1.91M | Sell |
|
|||||
|
2014
Q4 | $3.19M | Buy |
|
|||||
|
2014
Q3 | $1.93M | Sell |
|
|||||
|
2014
Q2 | $2.33M | Buy |
|